BCAAs | Total (n = 47,337) | Quintile 1 | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 | P for Non-linearity |
---|---|---|---|---|---|---|---|
Median intake (g/day) | 12.21 | 7.87 | 10.37 | 12.22 | 14.27 | 17.97 | |
All-cause mortality | |||||||
Number of deaths | 9,231 | 2,110 | 1,771 | 1,647 | 1,737 | 1,966 | |
Model 1 | 1.16 (1.07–1.24) | 1.05 (0.98–1.12) | Ref | 1.03 (0.96–1.10) | 1.17 (1.08–1.26) | < 0.001 | |
Model 2 | 1.15 (1.06–1.25) | 1.04 (0.97–1.12) | Ref | 1.02 (0.95–1.10) | 1.05 (0.95–1.15) | < 0.001 | |
Cardiovascular mortality | |||||||
Number of deaths | 4,215 | 979 | 784 | 736 | 795 | 921 | |
Model 1 | 1.10 (0.99–1.23) | 1.00 (0.91–1.11) | Ref | 1.08 (0.97–1.19) | 1.30 (1.17–1.45) | < 0.001 | |
Model 2 | 1.19 (1.05–1.34) | 1.05 (0.94–1.17) | Ref | 1.06 (0.95–1.18) | 1.07 (0.93–1.23) | 0.005 | |
Cancer mortality | |||||||
Number of deaths | 1,887 | 407 | 390 | 347 | 352 | 391 | |
Model 1 | 1.33 (1.13–1.56) | 1.19 (1.03–1.38) | Ref | 0.92 (0.76–1.06) | 0.90 (0.76–1.06) | 0.159 | |
Model 2 | 1.19 (0.99–1.42) | 1.09 (0.93–1.28) | Ref | 0.93 (0.79–1.09) | 0.98 (0.80–1.21) | 0.150 | |
Other mortality | |||||||
Number of deaths | 3,373 | 782 | 650 | 605 | 639 | 698 | |
Model 1 | 1.13 (1.00-1.27) | 1.04 (0.92–1.16) | Ref | 1.04 (0.93–1.16) | 1.17 (1.03–1.32) | < 0.001 | |
Model 2 | 1.08 (0.95–1.24) | 1.01 (0.90–1.14) | Ref | 1.04 (0.92–1.17) | 1.06 (0.91–1.24) | 0.112 |